LEO Pharma Receives Positive CHMP Opinion of Adtralza® (tralokinumab) for Atopic Dermatitis
If authorized, Adtralza® (tralokinumab) will be the first approved biologic that specifically targets the IL-13 cytokine The ...
Read more
Tag: Leo
If authorized, Adtralza® (tralokinumab) will be the first approved biologic that specifically targets the IL-13 cytokine The ...
Read more